Free Trial

CME Group Inc. (NASDAQ:CME) Shares Bought by Siemens Fonds Invest GmbH

CME Group logo with Finance background

Siemens Fonds Invest GmbH raised its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 50.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,335 shares of the financial services provider's stock after purchasing an additional 5,810 shares during the quarter. Siemens Fonds Invest GmbH's holdings in CME Group were worth $4,026,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of CME. Lake Street Advisors Group LLC boosted its position in shares of CME Group by 108.7% during the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider's stock valued at $2,949,000 after buying an additional 6,453 shares during the period. Unified Investment Management bought a new position in shares of CME Group during the fourth quarter valued at approximately $503,000. Spire Wealth Management boosted its position in CME Group by 37.4% during the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider's stock valued at $307,000 after acquiring an additional 359 shares in the last quarter. Aspire Growth Partners LLC purchased a new position in CME Group in the fourth quarter valued at about $548,000. Finally, Massachusetts Financial Services Co. MA lifted its position in CME Group by 18.8% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,169,999 shares of the financial services provider's stock valued at $503,939,000 after acquiring an additional 343,498 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on CME. Royal Bank of Canada reiterated a "sector perform" rating and issued a $269.00 target price on shares of CME Group in a research note on Thursday, April 3rd. JPMorgan Chase & Co. reduced their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. UBS Group lifted their price target on CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Barclays boosted their target price on CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a report on Wednesday, April 23rd. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $256.80.

Check Out Our Latest Research Report on CME Group

Insider Buying and Selling

In other news, COO Suzanne Sprague sold 1,500 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the sale, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. The trade was a 15.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the transaction, the director now owns 3,668 shares of the company's stock, valued at $1,035,916.56. This represents a 12.00% decrease in their position. The disclosure for this sale can be found here. Insiders sold 24,400 shares of company stock valued at $6,533,180 in the last three months. 0.30% of the stock is owned by corporate insiders.

CME Group Trading Down 0.0%

CME Group stock traded down $0.11 during midday trading on Thursday, reaching $285.87. 1,486,147 shares of the stock traded hands, compared to its average volume of 2,185,228. The firm has a market cap of $103.02 billion, a PE ratio of 29.56, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a 50-day simple moving average of $269.01 and a two-hundred day simple moving average of $250.25. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $287.05.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.50 earnings per share. Research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be paid a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.75%. CME Group's payout ratio is 50.30%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines